Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling

Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling

Bone marrow mesenchymal stem cells (BM MSCs) play a tumor-supportive role in promoting drug resistance and disease relapse in multiple myeloma (MM). Recent studies have discovered a sub-population of MSCs, known as inflammatory MSCs (iMSCs), exclusive to the MM BM microenvironment and implicated in...

Full description

Bibliographic Details
Main Authors:	Lei Wang, Weijun Yi, Li Ma, Emily Lecea, Lori A. Hazlehurst, Donald A. Adjeroh, Gangqing Hu
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	Cancers
Subjects:	multiple myeloma bone marrow inflammatory MSCs transcriptional signature IL-1β
Online Access:	https://www.mdpi.com/2072-6694/15/21/5148

Similar Items

Bone Marrow Stroma-Induced Transcriptome and Regulome Signatures of Multiple Myeloma
by: Sebastian A. Dziadowicz, et al.
Published: (2022-02-01)

Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma
by: Yu Lu, et al.
Published: (2024-03-01)

Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression
by: Patricia Maiso, et al.
Published: (2021-05-01)

Effect of ectopic high expression of transcription factor OCT4 on the “stemness” characteristics of human bone marrow-derived mesenchymal stromal cells
by: Xiaoping Guo, et al.
Published: (2019-06-01)

Soluble and Cell–Cell-Mediated Drivers of Proteasome Inhibitor Resistance in Multiple Myeloma
by: Mariah L. Farrell, et al.
Published: (2018-05-01)

In Osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis
by: Ana María Pino, et al.
Published: (2012-01-01)

Multiple myeloma presenting with coexisting severe marrow hypoplasia
by: Medhi K, et al.
Published: (2008-10-01)

Bone Marrow Stromal Cell-Derived IL-8 Upregulates PVR Expression on Multiple Myeloma Cells via NF-kB Transcription Factor
by: Abdelilah Mekhloufi, et al.
Published: (2020-02-01)

Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group
by: Jelena Bila, et al.
Published: (2021-08-01)

Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple Myeloma
by: Konstantinos Papadimitriou, et al.
Published: (2020-11-01)

Autologous Bone Marrow Transplant in Multiple Myeloma Patient With Bone Marrow Hematopoietic Stem Cell
by: D Santosa, et al.
Published: (2020-12-01)

The risk of renal disease is increased in lambda myeloma with bone marrow amyloid deposits
by: Kozlowski P, et al.
Published: (2017-03-01)

Relationship Between Serum Periostin Level and Bone Marrow Fibrosis in Newly Diagnosed Multiple Myeloma Patients
by: Ali Kürşat TUNA, et al.
Published: (2023-06-01)

Systemic Mastocytosis Associated with “Smoldering” Multiple Myeloma
by: Magda Zanelli, et al.
Published: (2021-01-01)

Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications
by: Jacqueline Schütt, et al.
Published: (2021-08-01)

Editorial: The role of the bone marrow microenvironment in multiple myeloma evolution and therapy
by: Carolina Schinke, et al.
Published: (2023-02-01)

Game of Bones: How Myeloma Manipulates Its Microenvironment
by: Tyler Moser-Katz, et al.
Published: (2021-02-01)

Neuroprotective Potential of Bone Marrow-Derived Mesenchymal Stem Cells Following Chemotherapy
by: Iman O. Sherif, et al.
Published: (2021-06-01)

Assessment of Bone Marrow Biopsy and Cytogenetic Findings in Patients with Multiple Myeloma
by: Ahmet Seyhanlı, et al.
Published: (2022-05-01)

Biological Characteristics and Osteogenic Differentiation of Ovine Bone Marrow Derived Mesenchymal Stem Cells Stimulated with FGF-2 and BMP-2
by: Sandra Gromolak, et al.
Published: (2020-12-01)

Interaction between Macrophages and Human Mesenchymal Stromal Cells Derived from Bone Marrow and Wharton’s Jelly—A Comparative Study
by: Marta Dymowska, et al.
Published: (2021-11-01)

Evaluation of Correlation between Serum Free Light-Chain Assay and Bone Marrow Study in Multiple Myeloma Patients
by: Fatemeh Zamani, et al.
Published: (2021-07-01)

Transplantation of CRISPRa system engineered IL10-overexpressing bone marrow-derived mesenchymal stem cells for the treatment of myocardial infarction in diabetic mice
by: Xin Meng, et al.
Published: (2019-05-01)

A Network Analysis of Multiple Myeloma Related Gene Signatures
by: Yu Liu, et al.
Published: (2019-09-01)

The role of bone marrow microenvironment in the progression of multiple myeloma from monoclonal gammopathy of undetermined significance
by: A. S. Khudovekova, et al.
Published: (2021-09-01)

The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma
by: Nikolaos Giannakoulas, et al.
Published: (2021-04-01)

A Journey through the Inter-Cellular Interactions in the Bone Marrow in Multiple Myeloma: Implications for the Next Generation of Treatments
by: Rosario Hervás-Salcedo, et al.
Published: (2022-08-01)

CHARACTERISTICS OF BONE MARROW MICROENVIRONMENT IN MULTIPLE MYELOMA BEFORE AND AFTER TREATMENT
by: V. I. Rugal, et al.
Published: (2019-03-01)

Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment
by: Matthew Ho, et al.
Published: (2022-11-01)

Comparative Study of Quality of Life in Multiple Myeloma Patients after Bone Marrow Transplantation in Outpatient and Inpatient Setting
by: A Manookian, et al.
Published: (2010-06-01)

Transient Receptor Potential C 1/4/5 Is a Determinant of MTI-101 Induced Calcium Influx and Cell Death in Multiple Myeloma
by: Osama M. Elzamzamy, et al.
Published: (2021-06-01)

Preconditioning in an Inflammatory Milieu Augments the Immunotherapeutic Function of Mesenchymal Stromal Cells
by: Luis A. Rodriguez, et al.
Published: (2019-05-01)

A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma
by: Dandan Gao, et al.
Published: (2023-02-01)

Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma
by: Yachun Jia, et al.
Published: (2023-09-01)

Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen
by: Arjen Gebraad, et al.
Published: (2022-05-01)

HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma
by: Luigia Rao, et al.
Published: (2020-01-01)

Extramedullary relapse of Immunoglobulin A-kappa myeloma manifesting as plasmacytoma of the pleura without bone marrow involvement and following autologous bone marrow transplant: a case report
by: Alireza Rezvani, et al.
Published: (2023-02-01)

Boosting Immunity against Multiple Myeloma
by: Raquel Lopes, et al.
Published: (2021-03-01)

Comparative Analysis of Biological Signatures between Freshly Preserved and Cryo-Preserved Bone Marrow Mesenchymal Stem Cells
by: Taesic Lee, et al.
Published: (2023-09-01)

Small volume bone marrow aspirates with high progenitor cell concentrations maximize cell therapy dose manufacture and substantially reduce donor hemoglobin loss
by: Jeremy Epah, et al.
Published: (2023-09-01)